• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart

  • COVID-19 Resources
  • Knowledge Center
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology
  • Diagnostics
  • Healthcare
  • Medical Devices
  • Pharmaceuticals

Knowledge Center Sidebar

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
  • Molecular Diagnostics Markets in the COVID-19 Era (Markets for COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)
    $5,500 – $11,000
    Molecular Diagnostics could be said to be the most important part of in vitro diagnostics.  This is especially true in the wake of COVID-19.  Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does […]
    July 9, 2020
  • Clinical Diagnostics MasterFile
    Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture […]
    June 30, 2020
  • Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
    $6,000 – $12,000
    Kalorama Information’s report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers […]
    June 17, 2020
  • Emerging Infectious Disease Diagnostics: Markets and Trends
    $3,000 – $6,000
    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number […]
    May 27, 2020
  • Hematology and Coagulation Markets (Lab-based and Decentralized Markets)
    $5,000 – $10,000
    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential […]
    May 19, 2020
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
    $4,000 – $8,000
    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the […]
    May 14, 2020
  • Outsourcing in Drug Discovery, 9th Edition
    $5,500 – $11,000
    Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug […]
    May 8, 2020
  • Cell Therapy and Gene Therapy Markets
    $5,500 – $11,000
    What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular […]
    April 27, 2020
  • Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
    $4,000 – $8,000
    The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine […]
    April 21, 2020
  • Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
    $750 – $1,000
    For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most […]
    April 7, 2020
Page 3 of 78‹12345›»

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report April 16, 2021
  • Global Biomarker Test Product Sales to Reach $63 Billion in 2027 April 14, 2021
  • Global IVD Procedures to Grow to 111.3 Billion Annually…Here’s Why April 7, 2021
  • FDA Approves Novel Cell Therapy for Multiple Myeloma March 30, 2021
  • COVID-19 Diagnostics Market Blog: Qiagen secures EUA for COVID-19 test – Labs Still Struggle with Supplies, Says CAP; Cue Health Gets At-Home Approval; FDA Tightens on Variants March 29, 2021

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register